Reproductive performance of dairy cows following treatment with cloprostenol 26 and/or 40 days postpartum: A field trial.

Reproductive performance of dairy cows following treatment with cloprostenol 26 and/or 40 days postpartum: A field trial. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Reproductive performance of dairy cows following treatment with cloprostenol 26 and/or 40 days postpartum: A field trial. Abstract Text:

W G Etherington,S W Martin,B Bonnett,W H Johnson,R B Miller,N C Savage,J S Walton,M E Montgomery,

One hundred and seventy Holstein Friesian cows were randomly assigned to receive either 500 ug cloprostenol or saline placebo on Day 26 postpartum followed by 500 ug cloprostenol or saline on Day 40 postpartum. Four treatment groups were formed: Group 1 - saline (Day 26)/saline (Day 40); Group 2 - cloprostenol/(Day 26) saline (Day 40); Group 3 - saline (Day 26)/cloprostenol (Day 40); Group 4 - cloprostenol (Day 26)/cloprostenol (Day 40). Double blind techniques were used in administering treatments and in assessing the response to treatment. Palpation of the reproductive tract per tectum and uterine biopsies were performed on 92 cows prior to each treatment at Day 26 and Day 40 postpartum. Progesterone concentrations were determined on milk samples collected prior to treatment. There were no significant differences among treatment groups with respect to services per conception, number of heats detected before first service and culling for infertility. Cloprostenol treatment at Day 26 appeared to delay the first estrus, but it reduced the number of days to conception after the first service. Cows receiving cloprostenol at Days 26 and/or 40 had a decreased calving-to-conception interval compared to controls (P = 0.01). Sequential therapy with two doses of cloprostenol resulted in slightly better reproductive performance than either treatment on Day 26 or 40 alone. Treatment with cloprostenol resulted in a decrease in the subsequent incidence of pyometra (P < 0.05). It is concluded that in the herd studied, cloprostenol therapy at Day 26 and/or 40 postpartum was beneficial to reproductive performance. Although it was anticipated that cloprostenol would be more effective in cows with elevated progesterone levels, the opposite was observed at the Day 26 cloprostenol treatment. Uterine biopsy at Days 26 and/or 40 had a detrimental effect on subsequent reproductive performance.

Reproductive performance of dairy cows following treatment with cloprostenol 26 and/or 40 days postpartum: A field trial. Publishing Authors By Initials

WG Etherington,SW Martin,B Bonnett,WH Johnson,RB Miller,NC Savage,JS Walton,ME Montgomery,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Reproductive performance of dairy cows following treatment with cloprostenol 26 and/or 40 days postpartum: A field trial. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Theriogenology

VOLUME: 29

Page Numbers: 565-75

Journal Abbreviation: Theriogenology

ISSN: 0093-691X

DAY: 26

MONTH: 05

YEAR: 1988

Reproductive performance of dairy cows following treatment with cloprostenol 26 and/or 40 days postpartum: A field trial. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 421510

Reproductive performance of dairy cows following treatment with cloprostenol 26 and/or 40 days postpartum: A field trial. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Reproductive performance of dairy cows following treatment with cloprostenol 26 and/or 40 days postpartum: A field trial. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Reproductive performance of dairy cows following treatment with cloprostenol 26 and/or 40 days postpartum: A field trial.

AFFILIATION: Department of Population Medicine, O.V.C., University of Guelph, Guelph, Ontario, N1G 2W1, Canada.

Country: United States

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Theriogenology

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Reproductive performance of dairy cows following treatment with cloprostenol 26 and/or 40 days postpartum: A field trial Related Publications

• A general synthesis of N-vinyl nitrones.
• Assay of the von Willebrand factor (VWF) propeptide to identify patients with type 1 von Willebrand disease with decreased VWF survival.
• Childbirth Education for the HIV-Positive Woman.
• Consistency of sentence intelligibility across difficult listening situations.
• Development of immortalized rat conjunctival epithelial cell lines: an in vitro model to examine transepithelial antigen delivery.
• Effects of GPi stimulation on human thalamic neuronal activity.
• Functional communication and executive function in aphasia.
• HIV and Pregnancy Web Sites.
• Highly diastereoselective preparation of anti-1,2-diols by catalytic addition of alkynylsilanes to alpha-silyloxyaldehydes.
• Influence of suckling frequency and bromocryptine treatment on the resumption of ovarian cycles in post-partum beef cattle.
• Information for working mothers.
• Managing violence.
• Maternal-newborn nursing: thirteen challenges that influence excellence in practice.
• Needle-sharing among young IV drug users and their social network members: The influence of the injection partner's characteristics on HIV risk behavior.
• New Resource from the CDC to Prevent Obesity: Perinatal Implications.
• Novel variants in growth differentiation factor 9 in mothers of dizygotic twins.
• Nutrition Column An Update on Water Needs during Pregnancy and Beyond.
• Nutrition and HIV-Positive Pregnancy.
• Planned adolescent pregnancy: themes related to the pregnancy.
• Remembrance of hypnosis past.
• Reproductive performance of dairy cows following treatment with cloprostenol 26 and/or 40 days postpartum: A field trial.
• Soy protein.
• The best practices: use of the guidelines by ten state tobacco control programs.
• Web Resources that Address Psychiatric Disorders in Pregnancy.
• Web Sites that Address Epidural Anesthesia for Childbirth.
• Web Sites that Address Gestational Diabetes and Perinatal Obesity.
• Web Sites that Address Perinatal Physical Activity.
• Web Sites that Address Postpartum Depression.
• Web site resources for high-risk families.
• Web site resources for waterbirth.